(D-Trp8)-Somatostatin-14

CAS No. 58976-46-8

(D-Trp8)-Somatostatin-14( ——— )

Catalog No. M40414 CAS No. 58976-46-8

[D-Trp8] Somatostatin-14, a tetradecapeptide, is an analog of Somatostatin more potent than the native Somatostatin.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (D-Trp8)-Somatostatin-14
  • Note
    Research use only, not for human use.
  • Brief Description
    [D-Trp8] Somatostatin-14, a tetradecapeptide, is an analog of Somatostatin more potent than the native Somatostatin.
  • Description
    [D-Trp8] Somatostatin-14, a tetradecapeptide, is an analog of Somatostatin more potent than the native Somatostatin.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    58976-46-8
  • Formula Weight
    1637.91
  • Molecular Formula
    C76H104N18O19S2
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. J Rivier, et al. D-Trp8-somatostatin: an analog of somatostatin more potent than the native molecule. Biochem Biophys Res Commun. 1975 Jul 22;65(2):746-51. ?
molnova catalog
related products
  • W-G

    L-Tryptophanylglycine (Trp-gly) is a dipeptide that can inhibit Ceronapril uptake by Caco-2 cells, with a Ki of 7.19 mM.

  • Kajiichigoside F1

    Kaji-ichigoside F1 shows antiinflammatory/antinociceptive action in acetic acid-induced writhing and hot plate testing and in a carrageenan-induced paw edema model in mice and rats.

  • Stearyl glycyrrhetin...

    Stearyl glycyrrhetinate the stearyl ester of 18-β-glycyrrhetinic acid has been demonstrated to improve antiviral effects reduce inflammation and suppress allergies in the pharmaceutical and cosmetic industry.